Selective Reduction in IVF: Nursing Ethics and Practice
This paper examines the ethical dilemmas surrounding selective reduction in cases where in-vitro fertilization produces multiple-fetus pregnancies. Drawing on the American Nurses Association Code of Ethics, the paper considers how nurses and other medical professionals must navigate the tension between patient dignity, professional duty, and personal moral or religious belief. It also discusses recent advances in blastocyst transfer technology, which may reduce the frequency of high-order multiple pregnancies, and argues that research into nurses' attitudes toward IVF and selective reduction could help clarify how the profession might approach this ethically complex issue.
- Introduction: Nursing Ethics and Multiple-Fetus Pregnancies: ANA ethics code meets IVF multiple-pregnancy dilemmas
- Selective Reduction: Procedure and Ethical Questions: Selective reduction explained and its ethical tensions
- Concerns About Future Misuse of Selective Reduction: Slippery slope fears over embryo selection criteria
- Advances in Blastocyst Transfer and Their Implications: Fifth-day blastocyst transfer reduces multiple-birth rates
- How Nurses' Personal Beliefs Shape Ethical Perspectives: Nurses' religious and moral views on IVF ethics
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It grounds the ethical argument in a recognized professional standard — the ANA Code of Ethics — giving the discussion an authoritative foundation.
- It balances scientific information (blastocyst transfer success rates) with ethical analysis, showing that technological advances can shift the moral landscape.
- It acknowledges multiple perspectives, including religious, moral, and professional viewpoints, without dismissing any of them.
Key academic technique demonstrated
The paper effectively uses a framing device: it opens with a professional code, then demonstrates how real-world medical practice creates tension with that code. This technique of establishing a normative standard before introducing a complicating scenario is a strong way to structure applied ethics arguments, as it gives readers a clear reference point against which competing positions can be measured.
Structure breakdown
The paper opens by establishing the ethical framework provided by the ANA Code of Ethics. It then introduces the clinical problem of multiple-fetus IVF pregnancies and the option of selective reduction, followed by broader concerns about future misuse. The paper pivots to a scientific development — blastocyst transfer — that may reduce the dilemma's frequency. It closes by returning to the nursing perspective, calling for further research into how nurses' personal beliefs influence their professional ethical stances.
Introduction: Nursing Ethics and Multiple-Fetus Pregnancies
One central tenet of the American Nurses Association Code of Ethics states, "the nurse provides services with respect for human dignity and the uniqueness of the client, unrestricted by considerations of social or economic status, personal attributes, or the nature of health problems." That seemingly simple statement puts nurses — as well as other medical professionals — in an ethical quandary when they consider the issue of in-vitro fertilization (IVF) that results in a pregnancy with multiple fetuses. Even the presence of twins instead of a singleton presents extra risks for both mother and babies, and those risks rise dramatically as the number of babies increases. However, in the recent past, fertility experts have felt it necessary to implant multiple fertilized eggs because of low individual success rates (Johnson, 1999).
Selective Reduction: Procedure and Ethical Questions
One option when a multiple pregnancy presents clear risks — especially to the likely viability of all babies — is selective reduction. In selective reduction, some of the fetuses are aborted to allow the others a greater chance of survival with quality of life. While such an action is taken in order to protect some of the fetuses, multiple ethical questions remain, including how to decide which embryos will be allowed to develop and which will be allowed to terminate. At this stage, doctors and parents may not yet know the sex of each embryo, and it may be too early to determine whether any of the embryos are at greater risk of being born with a significant defect than others.
Create your account
Always verify citation format against your institution’s current style guide requirements.